- Home
- CLST vs HOWL Comparison
CLST vs HOWL Comparison
Compare CLST & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- HOWL
- Stock Information
- Founded
- CLST 1922
- HOWL 2017
- Country
- CLST United States
- HOWL United States
- Employees
- CLST N/A
- HOWL N/A
- Industry
- CLST
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- CLST
- HOWL Health Care
- Exchange
- CLST Nasdaq
- HOWL Nasdaq
- Market Cap
- CLST 48.8M
- HOWL 50.3M
- IPO Year
- CLST N/A
- HOWL 2021
- Fundamental
- Price
- CLST $11.85
- HOWL $1.18
- Analyst Decision
- CLST
- HOWL Strong Buy
- Analyst Count
- CLST 0
- HOWL 3
- Target Price
- CLST N/A
- HOWL $8.33
- AVG Volume (30 Days)
- CLST 5.1K
- HOWL 643.1K
- Earning Date
- CLST 04-24-2025
- HOWL 05-08-2025
- Dividend Yield
- CLST N/A
- HOWL N/A
- EPS Growth
- CLST N/A
- HOWL N/A
- EPS
- CLST 0.57
- HOWL N/A
- Revenue
- CLST $11,257,000.00
- HOWL $1,143,000.00
- Revenue This Year
- CLST N/A
- HOWL N/A
- Revenue Next Year
- CLST N/A
- HOWL $900.00
- P/E Ratio
- CLST $21.12
- HOWL N/A
- Revenue Growth
- CLST 200.91
- HOWL N/A
- 52 Week Low
- CLST $10.67
- HOWL $0.60
- 52 Week High
- CLST $12.40
- HOWL $5.73
- Technical
- Relative Strength Index (RSI)
- CLST 62.86
- HOWL 61.01
- Support Level
- CLST $11.62
- HOWL $1.18
- Resistance Level
- CLST $12.00
- HOWL $1.31
- Average True Range (ATR)
- CLST 0.11
- HOWL 0.11
- MACD
- CLST 0.02
- HOWL 0.02
- Stochastic Oscillator
- CLST 100.00
- HOWL 68.83
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.